|
|
13
BIOCHINA 2025
Suzhou, China – BIOCHINA2024, a premier event in the biotechnology and pharmaceutical industries, successfully concluded with a record-breaking 27,931 registrants, 480 exhibitors, and 839 speakers from around the world. This year's event, held in Suzhou, highlighted cutting-edge advancements in drug licensing, supply chain optimization, product promotion, and funding access within the biotech sector.
Looking ahead, BIOCHINA 2025 has officially announced its next conference, set for March 13-15, 2025. The 10th edition of the event covering 50,000 square meters across five halls. Exhibitors will showcase a wide range of products and services, including pharmaceutical equipment, laboratory instruments, technical services, and raw materials, as well as reagents and consumables. International exhibitors will also be a key highlight.
BIOCHINA 2025 will associate with top-tier Chinese biotech and biopharmaceutical companies, covering key areas such as cell and gene therapy, antibody drugs, vaccines, small molecule drugs, peptide drugs, and nucleic acid drugs. This focus on advanced biotechnologies positions BIOCHINA 2025 as a central hub for innovation and collaboration in the industry.
22nd BioPharma Clinical Trials Nexus Conference
Welcome to the 22nd BioPharma Clinical Trials Nexus Conference, set to take place on March 13th - 14th in the vibrant city of Basel, Switzerland. Our conference agenda promises an insightful journey through the latest trends, innovations, and challenges in the clinical trials landscape. With five dynamic streams, we will delve into Clinical Trials Operations, Clinical Trials Outsourcing and Vendor Selection, Site Engagement & Sponsor Relationships, Digital Innovation and Technology in Clinical Trials, and Patient as Partners. Explore topics such as the transformative potential of AI in enhancing clinical operations, strategies for speeding up clinical development, the evolving landscape of patient recruitment, and the pursuit of true patient-centric trials. Join us in Basel, Switzerland as we chart the course to greater efficiency, collaboration, and innovation in clinical trials.
Register: nexus-conference.com/22nd-clinical-trials-reg
|
14
BIOCHINA 2025
Suzhou, China – BIOCHINA2024, a premier event in the biotechnology and pharmaceutical industries, successfully concluded with a record-breaking 27,931 registrants, 480 exhibitors, and 839 speakers from around the world. This year's event, held in Suzhou, highlighted cutting-edge advancements in drug licensing, supply chain optimization, product promotion, and funding access within the biotech sector.
Looking ahead, BIOCHINA 2025 has officially announced its next conference, set for March 13-15, 2025. The 10th edition of the event covering 50,000 square meters across five halls. Exhibitors will showcase a wide range of products and services, including pharmaceutical equipment, laboratory instruments, technical services, and raw materials, as well as reagents and consumables. International exhibitors will also be a key highlight.
BIOCHINA 2025 will associate with top-tier Chinese biotech and biopharmaceutical companies, covering key areas such as cell and gene therapy, antibody drugs, vaccines, small molecule drugs, peptide drugs, and nucleic acid drugs. This focus on advanced biotechnologies positions BIOCHINA 2025 as a central hub for innovation and collaboration in the industry.
22nd BioPharma Clinical Trials Nexus Conference
Welcome to the 22nd BioPharma Clinical Trials Nexus Conference, set to take place on March 13th - 14th in the vibrant city of Basel, Switzerland. Our conference agenda promises an insightful journey through the latest trends, innovations, and challenges in the clinical trials landscape. With five dynamic streams, we will delve into Clinical Trials Operations, Clinical Trials Outsourcing and Vendor Selection, Site Engagement & Sponsor Relationships, Digital Innovation and Technology in Clinical Trials, and Patient as Partners. Explore topics such as the transformative potential of AI in enhancing clinical operations, strategies for speeding up clinical development, the evolving landscape of patient recruitment, and the pursuit of true patient-centric trials. Join us in Basel, Switzerland as we chart the course to greater efficiency, collaboration, and innovation in clinical trials.
Register: nexus-conference.com/22nd-clinical-trials-reg
|
15
BIOCHINA 2025
Suzhou, China – BIOCHINA2024, a premier event in the biotechnology and pharmaceutical industries, successfully concluded with a record-breaking 27,931 registrants, 480 exhibitors, and 839 speakers from around the world. This year's event, held in Suzhou, highlighted cutting-edge advancements in drug licensing, supply chain optimization, product promotion, and funding access within the biotech sector.
Looking ahead, BIOCHINA 2025 has officially announced its next conference, set for March 13-15, 2025. The 10th edition of the event covering 50,000 square meters across five halls. Exhibitors will showcase a wide range of products and services, including pharmaceutical equipment, laboratory instruments, technical services, and raw materials, as well as reagents and consumables. International exhibitors will also be a key highlight.
BIOCHINA 2025 will associate with top-tier Chinese biotech and biopharmaceutical companies, covering key areas such as cell and gene therapy, antibody drugs, vaccines, small molecule drugs, peptide drugs, and nucleic acid drugs. This focus on advanced biotechnologies positions BIOCHINA 2025 as a central hub for innovation and collaboration in the industry.
|
|
|